Subtle Medical secured $33 million to accelerate its AI image enhancement solutions for radiology.
Key Details
- 1Subtle Medical raised $33 million in growth capital, bringing total funding to approximately $86 million.
- 2The funding was led by Morgan Stanley Expansion Capital, with participation from several new and existing investors.
- 3Subtle's AI solutions (SubtleHD(MR) for MRI, and SubtlePET for PET) speed up scan times while maintaining image quality.
- 4SubtlePET received FDA 510(k) clearance in May and can reduce PET scan times by up to 75%.
- 5The technology is deployed on about 1,300 scanners worldwide, across major institutions like Mount Sinai and RadNet.
Why It Matters
Expanded funding allows Subtle Medical to further develop and deploy its vendor-neutral AI solutions, enhancing efficiency and patient throughput across radiology departments globally. Rapid scan times and improved imaging quality are key benefits for healthcare providers adopting AI technologies.
Source
Radiology Business
Related News
•Radiology Business
AI Technique Unveils Previously Hidden MS Gray Matter Lesions on MRI
Researchers developed an AI-enhanced method to detect previously invisible gray matter lesions in multiple sclerosis using MRI.
•Cardiovascular Business
AI Is Quietly Embedded in Cardiac Imaging Workflows
AI is now seamlessly integrated into cardiac imaging, often unnoticed by clinicians.
•Radiology Business
AI Tool Dramatically Reduces Breast MRI Scan Time
A new AI-enabled MRI technique significantly speeds up breast imaging while enhancing image quality and tumor detection.